Clinical Trials

Di Pierro2012
Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media
https://pubmed.ncbi.nlm.nih.gov/23233809/
Di Pierro et al.2013
Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults
https://pubmed.ncbi.nlm.nih.gov/23286823/
Di Pierro et al.2014
Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children
https://pubmed.ncbi.nlm.nih.gov/24600248/
Di Pierro et al.2015
Oral Use of Streptococcus Salivarius K12 in Children with Secretory Otitis Media
https://pubmed.ncbi.nlm.nih.gov/26396541/
Di Pierro2016
Positive clinical outcomes derived from using Streptococcus salivarius K12 to prevent streptococcal pharyngotonsillitis in children
https://pubmed.ncbi.nlm.nih.gov/27920580/
Gregori et al.2016
Reduction of group A beta-hemolytic streptococcus pharyngo-tonsillar infections
https://pubmed.ncbi.nlm.nih.gov/26855579/
Year